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Abstract
A multitude of different virulence factors as well as the ability to rapidly adapt to adverse environmental conditions are
important features for the high pathogenicity of Pseudomonas aeruginosa. Both virulence and adaptive resistance are tightly
controlled by a complex regulatory network and respond to external stimuli, such as host signals or antibiotic stress, in a
highly specific manner. Here, we demonstrate that physiological concentrations of the human host defense peptide LL-37
promote virulence factor production as well as an adaptive resistance against fluoroquinolone and aminoglycoside
antibiotics in P. aeruginosa PAO1. Microarray analyses of P. aeruginosa cells exposed to LL-37 revealed an upregulation of
gene clusters involved in the production of quorum sensing molecules and secreted virulence factors (PQS, phenazine,
hydrogen cyanide (HCN), elastase and rhamnolipids) and in lipopolysaccharide (LPS) modification as well as an induction of
genes encoding multidrug efflux pumps MexCD-OprJ and MexGHI-OpmD. Accordingly, we detected significantly elevated
levels of toxic metabolites and proteases in bacterial supernatants after LL-37 treatment. Pre-incubation of bacteria with LL-
37 for 2 h led to a decreased susceptibility towards gentamicin and ciprofloxacin. Quantitative Realtime PCR results using a
PAO1-pqsE mutant strain present evidence that the quinolone response protein and virulence regulator PqsE may be
implicated in the regulation of the observed phenotype in response to LL-37. Further experiments with synthetic cationic
antimicrobial peptides IDR-1018, 1037 and HHC-36 showed no induction of pqsE expression, suggesting a new role of PqsE
as highly specific host stress sensor.
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Introduction
Pseudomonas aeruginosa is a widespread Gram-negative water and
soil bacterium, which is, in addition, one of the most important
opportunistic human pathogens causing severe infections in
immunocompromised persons, such as burn wound, catheter
and urinary tract infections or chronic pneumonia in cystic fibrosis
(CF) patients [1]. Due to a large arsenal of intrinsic resistance
mechanisms such as a low outer membrane permeability, the
expression of antibiotic cleaving enzymes, and the existence of
multidrug efflux pump systems, P. aeruginosa is inherently resistant
to various commonly used antibiotics [2,3].
Multiple virulence factors have been identified to affect the
pathogenicity of P. aeruginosa. These factors comprise the
expression of extracellular appendices flagella, type IV pili and
type III secretion systems, the production of alginate and
lipopolysaccharide (LPS) and the synthesis of secreted exocom-
pounds such as proteases (e.g. elastase) and other enzymes, toxins,
phenazines, rhamnolipids, hydrogen cyanide (HCN) and quorum
sensing molecules (e.g. 4-quinolone PQS) [4,5]. P. aeruginosa
virulence is controlled by a highly complex and in large parts
not fully understood signaling network including the Las, Rhl and
PQS quorum sensing systems which induce the expression of
various virulence factors e.g. in response to high cell densities or
other external stimuli like iron limitation [6].
Adaptive resistance in P. aeruginosa has been reported for
aminoglycosides and different cationic antibiotics such as poly-
myxins and the bovine cationic peptide indolicidin. Although the
phenomena of adaptive resistance against the aminoglycoside
gentamicin and the polypeptide antibiotic polymyxin B was first
mentioned decades ago [7,8], the underlying signaling pathways
and involved defense mechanisms have been elucidated in parts in
recent studies [9,10,11,12,13]. While the two-component systems
PhoP-PhoQ and PmrA-PmrB recognize low Mg2+ concentrations
and phosphate deprivation in the environment, ParR-ParS and
CprR-CprS have been shown to directly sense cationic com-
pounds, such as polymyxin B, colistin, indolicidin and, amongst
others, the synthetic antimicrobial peptides HHC-36 and IDR-
1018 [12,13]. Activation of mentioned two-component systems
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induces the expression of the LPS modifying operon arnBCADTE-
Fugd, leading to a reduced net charge of LPS due to the addition of
4-aminoarabinose to lipid A, which impairs the self-promoted
uptake of cationic compounds across the outer membrane and
thereby enhances tolerance to these compounds [4,14].
The increasing occurrence of infections caused by multidrug-
resistant bacteria, which tolerate even high concentrations of
common antibiotics, calls for the rapid development and clinical
application of new anti-infective strategies [15]. Host defense
peptides, also termed as antimicrobial peptides (AMPs), have been
considered as promising compounds to combat multi-resistant
pathogens due to their combinatory actions as antimicrobial,
antibiofilm and immunomodulatory agents [15]. The major
human host defense peptide, LL-37, is the only cathelicidin class
peptide produced in humans and exhibits a modest antibacterial
activity against a variety of different pathogens including
Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus pneumonia
and P. aeruginosa [16]. Additionally, it has been shown to prevent
the formation of resistant biofilms and stimulate biofilm dispersal
in various bacteria when applied at sublethal concentrations [17].
LL-37 is synthesized by phagocytes, epithelial cells and keratino-
cytes and has been detected in a large number of different cells,
tissues and body fluids at varying concentrations [16]. During
infectious diseases, immune cells and epithelial cells secrete a
battery of host defense compounds, with either direct antimicro-
bial or immunomodulatory activities, including cationic peptides
[5]. Extracellular LL-37 levels have been observed to be severely
increased, reaching local concentrations of 15–20 mg/ml e.g. in
the lung fluid of newborns suffering from pulmonary infections
[18] and in cystic fibrosis patients [19] – diseases, which are often
linked to P. aeruginosa infections [1].
Previous studies demonstrated an influence of human opioids
[20,21], natriuretic peptides [22], INF-c [23] and the polypeptide
antibiotic colistin [24] on virulence and quorum sensing in P.
aeruginosa. However, this has not been investigated for human
cationic host defense peptides so far. In this study, we elucidated
the response of P. aeruginosa towards physiological concentrations
of LL-37 by global transcriptional studies and metabolite analyses
and observed a strong induction of virulence factor production as
well as an increase in efflux pump expression during incubation
with LL-37. Further experiments revealed an involvement of the
quinolone signal response protein PqsE in the regulation of this
LL-37 stimulated enhanced virulence factor production and
adaptive resistance in P. aeruginosa.
Materials and Methods
Bacterial Strains, Media and Antimicrobial Peptides
Bacterial strains used in this study are listed in Table 1.
Transposon mutants PAO1-pqsE and PA14-mexH were confirmed
by PCR (data not shown). All experiments were performed in
Mueller Hinton (MH) broth (Merck, Darmstadt, Germany).
Bacteria were routinely grown at 37uC with shaking at 170 rpm.
Antimicrobial peptides were kindly provided by Prof. Robert
Hancock (University of British Columbia, Vancouver, Canada) or
purchased from Anaspec (Fremont, CA, USA). The amino acid
sequences of antimicrobial peptides used and their minimal
inhibitory concentrations (MIC) against PAO1 WT are shown in
Table 2. Peptide stock solutions of 2 mg/ml were prepared in
sterile ultra pure DI water and stored at 220uC until needed.
MIC (Minimal Inhibitory Concentration) Determination
MIC values were determined using a standard broth micro-
dilution protocol as described previously [25]. Growth in MH
medium in presence or absence of antibiotics or antimicrobial
peptides was monitored after 18 h of incubation at 37uC. In case
of experiments with cationic peptides, 96-well polypropylene
microtiter plates (Eppendorf, Hamburg, Germany) were used in
order to prevent high MIC values due to the binding of cationic
peptides to polystyrene. MIC values against antibiotics ciproflox-
acin and gentamicin were determined in 96-well polystyrene
microtiter plates (Nunc, Thermo Fisher Scientific, St. Leon-Rot,
Germany).
RNA Extraction, cDNA Synthesis and Microarray Analysis
For global gene expression studies, three independent mid-log
phase cultures of P. aeruginosa PAO1 were challenged with LL-37
(20 mg/ml) for 2 h. Untreated bacterial cultures served as negative
controls. To ensure homogenous gene expression profiles within
treated and untreated groups enabling a precise analysis of
transcriptional changes, we used bacteria from the exponential
growth phase. Due to the higher cell number in this experiment
(,56108 cells/ml) in comparison to the MIC assay (56105 cells/
ml), used LL-37 concentrations of 20 mg/ml did not affect
bacterial growth during the incubation time. This was confirmed
by measuring the optical density of bacterial cultures at 600 nm
(OD600), resulting in comparable OD600 values in the range of
0.7–1.2 in treated samples and untreated controls after 2 h of
incubation. Following peptide treatment, total RNA was extracted
using RNA protect reagent and RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s instructions.
Remaining contaminating DNA was removed from the samples in
an off-column DNAse digestion procedure using AmbionH DNA-
freeTM Kit (Life Technologies GmbH, Darmstadt, Germany).
RNA quantity and quality was checked photometrically.
First strand cDNA synthesis from 10 mg total RNA as well as
cDNA fragmentation into 50–200 bp fragments, biotin-labeling
and subsequent hybridization to Affymetrix GeneChip DNA Micro-
arrays Pae_G1a was carried out according to the manufacturer’s
standard protocol (Affymetrix UK Ltd, Freiburg, Germany). Each
sample was hybridized to at least two microarray chips as technical
repeat. Only genes which showed more than 1.5-fold changes in
gene expression between LL-37-treated bacteria and untreated
controls were included in further analyses.
Quantitative Real Time PCR (qRT-PCR)
Quantitative Realtime PCR (qRT-PCR) experiments were
performed in order to verify microarray results of specific
dysregulated genes. To this aim, P. aeruginosa cultures were grown
until mid-exponential phase following incubation with peptides
LL-37, IDR-1018, 1037 or HHC-36 (20 mg/ml each; MIC values:
16 mg/ml (Table 2)) for 2 h as described for microarray analysis.
Isolation of total RNA was carried out using RNA protect reagent
and the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to
the manufacturer’s instructions. Remaining contaminating DNA
was removed from the samples in an off-column DNAse digestion
procedure using AmbionH DNA-freeTM Kit (Life Technologies
GmbH, Darmstadt, Germany). RNA quantity and quality was
checked photometrically. RNA was converted into first strand
cDNA using random hexamers and Maxima Reverse Transcrip-
tase (Thermo Fisher Scientific, St. Leon-Rot, Germany) in a
standard PCR protocol which was provided by the manufacturer.
cDNA was diluted to a concentration of 4 ng/ml and directly
utilized as template for qRT-PCR reactions using the KAPA
SYBR Fast Universal qPCR MasterMix (Peqlab Biotechnologie
GmbH, Erlangen, Germany) in an Abi 7300 Real Time PCR
System (Applied Biosystems Deutschland, Darmstadt, Germany)
as described previously [26]. Analysis of melting curves of PCR
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products ensured specificity of the PCR reactions. Primers used for
determination of P. aeruginosa gene expression were designed with
Primer Express (Applied Biosystems Deutschland, Darmstadt,
Germany). Primer sequences are shown in Table S1. Obtained
ct-values were normalized to the expression of housekeeping gene
rpoD which was not affected by LL-37 treatment as shown by
microarray analysis. Samples were assayed at least three times in
duplicate (n$6).
Time-killing Curves
PAO1 WT cultures were grown to mid-log phase and then
incubated with LL-37 (20 mg/ml) or without peptide as controls
for 2 h at 37uC in MH broth. Following dilution of bacterial
cultures to 107 cells/ml in MH broth, antibiotics ciprofloxacin
(0.18 mg/ml) or gentamicin (1.5 mg/ml) were added at 3-fold MIC
concentrations. Samples were serially diluted and plated out on LB
agar after 0, 2, 5, 7, 10, 15, 20, 30, 60 and 90 min of incubation
using an optimized drop plate method [27]. Experiments were
conducted in triplicates, each with an independent bacterial
culture.
Measurement of Pyocyanin and Elastase Activity
For detection and quantification of virulence-associated metab-
olites and enzymes, PAO1 WT mid-log phase cultures were
incubated with 20 mg/ml LL-37 for 21 h. Untreated cultures
served as negative controls. Following peptide treatment, bacteria
were spun down by centrifugation (30 min, 90006g, 4uC) and the
supernatants were passed through a 0.22 mm syringe filter
(Sarstedt, Nu¨mbrecht, Germany).
Pyocyanin was extracted from 2 ml supernatant by adding 2 ml
chloroform following re-extraction with 2 ml 0.2 M HCl and
subsequent measurement of absorption at 520 nm (A520) as
described previously [28]. A520 was normalized against OD600 of
the bacterial culture.
Elastase activity in supernatants was determined by an elastin
congo red (ECR) assay which was previously described by Pearson
et al. [29]. Elastolytic levels were normalized against the cell
density of each sample (OD600).
Pyocyanin and elastase activity analyses were performed at least
with six independent bacterial cultures. All data was statistically
analyzed using the non-parametric Mann-Whitney test.
PQS Measurement by Liquid Chromatography/Tandem
Mass Spectrometry (LC-MS/MS)
Supernatants of PAO1 WT bacteria grown for 21 h in the
presence or absence of LL-37 were obtained as described above
for pyocyanin and elastase analyses. Supernatants were mixed with
2 volumes dichloromethane and vortexed for 1 min. After
Table 1. P. aeruginosa strains used in this study.
Strain Description Reference
PAO1 WT H103 (PAO1 wild-type strain) [61]
PAO1-pqsE Transposon insertion in pqsE (PA1000), Mutant ID PAO1_lux_76:C11, TcR [38]
K767 Wild-type of strains K1521, K1536, K1523, K1455, K1525, K2415, K2896 [57]
K1521 K767DmexCD [57]
K1536 K767DnfxB [57]
K1523 K767DmexB [57]
K1455 K767DnalB [62]
K1525 K767DmexXY [63]
K2415 K767DmexZ [63]
K2896 K767 DmexBDmexCDDmexXY [57]
K2153 Clinical isolate, wild-type of efflux mutants K2892 and K2376 [64]
K2892 K2153DmexF [64]
K2376 K2153DmexS [64]
PA14 WT PA14 wild-type strain [65]
PA14-mexH Transposon insertion in mexH (PA4206), Mutant ID: PAMr_nr_mas_09_3:C7, GmR [65]
GmR: gentamicin resistance, TcR: tetracycline resistance.
doi:10.1371/journal.pone.0082240.t001
Table 2. Antimicrobial peptides used in this study.
Peptide Sequence Source/Reference MIC [mg/ml] against PAO1 WTa
LL-37 LLGDFFRKSKEKIFKEFKRIVQRIKDFLRNLVPRTES [66] 16
HHC-36 KRWWKWWRR [47] 16
IDR-1018 VRLIVAVRIWRR [45] 16
1037 KRFRIRVRV [46] 16
aMinimal inhibitory concentrations (MIC) of PAO1 WT against different antimicrobial peptides were determined in MH broth using a standard two-fold serial dilution
protocol for microtiter plates. Data represent mode MIC values of three independent experiments for each strain.
doi:10.1371/journal.pone.0082240.t002
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centrifugation (10 min, 90006g, 4uC), the lower organic layer
containing PQS was transferred into a new reaction tube following
evaporation under nitrogen gas at room temperature. The pellet
was then resuspended in pure methanol following quantification
by LC-MS/MS. To this aim, a quaternary HPLC pump and an
autosampler of the series 200 from Perkin Elmer (U¨berlingen,
Germany) were used. The protocol was adapted from two
methods described previously [30,31] with the following modifi-
cations. The separation was performed on a Zorbax Eclipse XCB-
C8 5 mm, 15063.6 mm HPLC column (Agilent, USA). The
mobile phase consisted of acetonitrile - water 80:20 (v/v) with
100 mM EDTA and 0.1% acetic acid at a flow rate of 0.40 ml/
min. The injection volume was set to 10 ml per sample. Electro-
Spray-Ionisation (ESI)-MS was performed on an API 365 triple
quadrupole mass spectrometer (PE Sciex, Toronto, Canada) using
a turbo ion spray interface used in positive mode. Single MS
experiments (Q1 scan), MS/MS experiments (product ion scan,
PIC) and multiple reaction monitoring (MRM) were performed
using nitrogen as curtain gas, nebulizer gas, heater gas and
collision gas. Instrumental parameters were optimized by infusion
experiments with PQS standard solution (10 mg/mL; Sigma-
Aldrich, Seelze, Germany) infused into the mass spectrometer
using a syringe pump (Harvard Apparatus Inc. South Natick, MA,
USA) at a flow rate of 10 ml/min. To quantify PQS with high
selectivity and sensitivity, MRM experiments were performed
using the transitions from precursor ion to fragment ion: 260/175
(quantifier), 260/146, 260/147 and 260/188 (qualifier). An
external calibration was performed using PQS standard solutions
with concentrations ranging from 10 ng/ml up to 1000 ng/ml.
PQS concentrations were normalized against the cell density of
each sample (OD600). Analyses were performed with six indepen-
dent bacterial cultures and data was statistically analyzed using the
non-parametric Mann-Whitney test.
HCN/CN2 Quantification
In order to determine levels of toxic HCN in response to LL-37,
P. aeruginosa cultures were grown until mid-log phase followed by
2 h of incubation with LL-37 (20 mg/ml) or without peptide as
negative control. Subsequently, cells were sedimented by centri-
fugation (30 min, 90006g, 4uC) and supernatants were passed
through a 0.22 mm syringe filter (Sarstedt, Germany). Quantifica-
tion of HCN/CN2 production was carried out using a polaro-
graphic approach delevoped by Blier et al. [32]. Since HCN/CN2
production in P. aeruginosa mainly occurs during the exponential
growth phase with a peak after 5 h post-inoculation [32], samples
for HCN quantification were taken 2 h after LL-37 addition,
which corresponds to the late log phase of bacterial growth. Mean
values and pooled standard deviations were calculated from three
independent experiments, each measured in triplicate, and
normalized to OD600 values. Statistical significance was verified
by a two-sided t-test for independent samples.
Microarray Data Accession Number
Complete microarray data is deposited in ArrayExpress under
accession number E-MEXP-3970.
Results
LL-37 Induces the Expression of Virulence Factor
Synthesis and Multidrug Efflux Pump Genes in P.
aeruginosa PAO1
In order to get a detailed insight into the global response of P.
aeruginosa to physiological concentrations of the human host
defense peptide LL-37, we performed gene expression studies
using DNA microarray technology. To this aim, mid-log phase P.
aeruginosa cells were exposed to 20 mg/ml LL-37 for 2 h following
RNA extraction and transcriptional analysis. Untreated cultures
served as negative controls. Determined OD600 values were
comparable in treated P. aeruginosa samples and control cultures,
ranging between 0.7 and 1.2 after the incubation time of 2 h,
which confirmed that growth was not inhibited by applied LL-37
concentrations. Additional CFU counts showed furthermore that
the relation between OD600 and cell counts was not altered by the
applied peptide concentrations. An OD600-value of 1.0 corre-
sponded to 0.860.26109 CFU/ml in control cultures and to
1.160.36109 CFU/ml in LL-37-treated samples after 2 h of
incubation.
Regarding microarray results, comparison of LL-37-treated
bacteria with untreated controls revealed a total number of 420
dysregulated genes (cut-off: 1.5-fold up- or downregulation), of
which 280 genes were upregulated and 140 genes were
downregulated (Tables 3, S2 and S3). Figure 1 summarizes the
functions of dysregulated genes in response to LL-37 and illustrates
the diversity of P. aeruginosa stress response to LL-37, since 21 out
of the 25 defined gene function classes [33] were affected by the
cationic peptide. Quantitative RT-PCR experiments on selected
genes were performed in order to confirm microarray data
(Table 4).
Most strikingly, the microarray data showed an upregulation by
2–8-fold of gene clusters involved in quorum sensing molecule and
virulence factor synthesis. Among these were genes coding for the
Pseudomonas quinolone signal (PQS) – pqsABCD (PA0996–0999) -
and the production of secreted toxic metabolites phenazine
(PA0051, PA1001/1002, PA1901–1905, PA4209–4211,
PA4217), HCN (PA2193–2195), elastase (PA1871, PA3724) and
rhamnolipids (PA3478/3479, PA1130) (Table 3). PqsE (PA1000),
which is involved in the regulation of virulence factor expression,
influencing e.g. pyocyanin, rhamnolipid and HCN production [6],
was also 2-fold upregulated during LL-37 incubation. Although
expression of rhamnolipid biosynthesis genes rhlA (PA3479), rhlB
(PA3478) and rhlC (PA1130) was enhanced by LL-37 contact, the
two main regulators of rhamnolipid production, rhlI (PA3476) and
rhlR (PA3477) [34] were not induced (see Tables S2 and S3).
Additional qRT-PCR experiments indicated rather a downregu-
lation of major quorum sensing regulators rhlR (fold change
22.060.3) and lasR (fold change 21.960.5) in response to LL-37.
In general, only a few genes (in total 9) encoding transcriptional
regulators were more than 1.5-fold upregulated by LL-37 (see
Table S2).
In accordance with previous studies [9,12], we observed an
induction of the arnBCADTEFugd LPS modification operon
(PA3552-3559) and the two-component regulator pmrA
(PA4776). In addition, our microarray data demonstrated an
upregulation of Resistance Nodulation Division (RND) efflux
pumps genes mexCD-oprJ (PA4597-4599) and mexGHI-opmD
(PA4205-4208), which are also involved in multidrug resistance
of P. aeruginosa by exporting antibiotics and other toxic compounds
[3,35,36,37], whereas genes encoding porin proteins were
downregulated by LL-37 (Table 3).
Susceptibility of Different P. aeruginosa Efflux Mutant
Strains to LL-37
Since we observed an upregulation of two RND efflux pump
systems in response to LL-37, we performed LL-37 susceptibility
tests with respective efflux pump mutants PA14-mexH and K1521
(K767DmexCD-oprJ) in comparison to the corresponding wild-type
strains PA14 and K767. Additional experiments included efflux
mutants K1523 (K767DmexB), K1525 (K767DmexXY) and K2892
LL-37 Stimulates Pathogenesis in P. aeruginosa
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Table 3. Microarray results of selected dysregulated genes of P. aeruginosa PAO1 WT in response to 2 h of incubation with LL-37
(20 mg/ml) compared to untreated controls.
PA number Gene name Gene product
Fold change in gene
expression
PQS biosynthesis and response (quorum sensing, virulence factor)
PA0996 pqsA Probable coenzyme A ligase +2.1
PA0997 pqsB PqsB +1.9
PA0998 pqsC PqsC +1.6
PA0999 pqsD 3-oxoacyl-[acyl-carrier-protein] synthase III +1.7
PA1000 pqsE Quinolone signal response protein +2.1
Pyocyanin biosynthesis (virulence factor)
PA0051 phzH Potential phenazine-modifying enzyme +1.6
PA1001 phnA Phenazine biosynthesis protein PhnA +2.0
PA1002 phnB Phenazine biosynthesis protein PhnB +2.2
PA1901 phzC2 Phenazine biosynthesis protein PhzC +4.7
PA1902 phzD2 Phenazine biosynthesis protein PhzD +5.8
PA1903 phzE2 Phenazine biosynthesis protein PhzE +6.1
PA1904 phzF2 Probable phenazine biosynthesis protein +6.0
PA1905 phzG2 Probable pyridoxamine 59-phosphate oxidase +6.3
PA4209 phzM Probable phenazine-specific methyltransferase +5.3
PA4210 phzA1 Probable phenazine biosynthesis protein +7.8
PA4211 phzB1 Probable phenazine biosynthesis protein +4.5
PA4217 phzS Flavin-containing monooxygenase +5.3
Elastase biosynthesis (virulence factor)
PA1871 lasA LasA protease precursor +1.8
PA3724 lasB Elastase LasB +2.1
Hydrogen cyanide (HCN) production (virulence factor)
PA2193 hcnA Hydrogen cyanide synthase HcnA +2.4
PA2194 hcnB Hydrogen cyanide synthase HcnB +2.6
PA2195 hcnC Hydrogen cyanide synthase HcnC +2.1
Rhamnolipid production
PA1130 rhlC Rhamnosyltransferase 2 +2.2
PA3478 rhlB Rhamnosyltransferase chain B +2.0
PA3479 rhlA Rhamnosyltransferase chain A +1.5
Porins, efflux pumps
PA3279 oprP Phosphate-specific outer membrane porin OprP precursor 25.5
PA3280 oprO Pyrophosphate-specific outer membrane porin OprO precursor 28.2
PA4205 mexG Hypothetical protein +10.2
PA4206 mexH Probable RND efflux membrane fusion protein precursor +4.9
PA4207 mexI Probable RND efflux transporter +2.5
PA4208 opmD Probable outer membrane protein precursor +3.1
PA4597 oprJ Multidrug efflux outer membrane protein OprJ precursor +3.7
PA4598 mexD RND multidrug efflux transporter MexD +4.4
PA4599 mexC RND multidrug efflux membrane fusion protein MexC precursor +9.1
PA4600 nfxB Transcriptional regulator NfxB +1.9
Lipopolysaccharide (LPS) modification
PA3552 arnB ArnB +1.6
PA3553 arnC ArnC +1.6
PA3555 arnD ArnD +1.5
PA3556 arnT Inner membrane L-Ara4N transferase ArnT +2.0
PA3557 arnE ArnE +2.0
PA3558 arnF ArnF +2.2
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(K2153DmexF) and K2153, the wild-type strain of K2892. All
tested efflux mutants and corresponding wild-type strains showed
identical MIC values for LL-37 (16 mg/ml for PA14-mexH, K1521,
K1523, K1525 and wild-types PA14 WT and K767; 32 mg/ml for
K2892 and wild-type K2153), indicating no impact of a single
pump knockout of either MexAB-OprM, MexCD-OprJ, MexXY-
OprM, MexEF-OprN or MexGHI-OpmD on susceptibility to LL-
37. Since export of many antibiotics is not restricted to one
individual efflux pump [3], in case of a single pump knockout,
other efflux systems could eventually take over functions of missing
efflux pumps, resulting in unaffected MIC values. To test whether
a multiple knockout of main P. aeruginosa RND efflux pumps
MexAB-OprM, MexXY-OprM and MexCD-OprJ affects suscep-
tibility to LL-37, MIC values were determined for triple mutant
K2896 (K767DmexBDmexCDDmexXY) and wild-type K767, both
exhibiting identical MIC values of 16 mg/ml. Next, we could show
that susceptibility to LL-37 was not influenced by overexpression
of efflux pumps MexAB-OprM (K1455), MexCD-OprJ (K1536),
MexXY-OprM (K2415) or MexEF-OprN (K2376) which also
resulted in equal MIC values compared to corresponding wild-
types K767 (16 mg/ml) or K2153 (32 mg/ml).
In summary, we conclude that susceptibility of P. aeruginosa
PAO1 to LL-37 is independent of the tested efflux systems,
Table 3. Cont.
PA number Gene name Gene product
Fold change in gene
expression
PA3559 ugd Probable nucleotide sugar dehydrogenase +2.8
Two-component system PmrA-PmrB
PA4773 Hypothetical protein +4.9
PA4774 Hypothetical protein +3.2
PA4775 Hypothetical protein +2.2
PA4776 pmrA Two-component regulator system response regulator PmrA +1.9
doi:10.1371/journal.pone.0082240.t003
Figure 1. Summarized microarray data of dysregulated P. aeruginosa genes in response to LL-37. Mid-log phase cultures of P. aeruginosa
PAO1 were grown in MH broth containing either 20 mg/ml LL-37 or no LL-37 for 2 h at 37uC following RNA extraction and microarray analysis. The
graph shows functions of more than 1.5-fold up- or downregulated genes according to the Pseudomonas Genome Database [28]. Hypothetical genes
are not shown.
doi:10.1371/journal.pone.0082240.g001
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although expression of RND efflux pump MexCD-OprJ was
upregulated in response to LL-37 in our gene expression studies.
LL-37 Enhances Antibiotic Resistance of P. aeruginosa
PAO1 Towards Fluoroquinolone and Aminoglycoside
Antibiotics
To investigate whether LL-37 was able to trigger adaptive
resistance mechanisms in P. aeruginosa towards different antibiotics,
time dependent killing of P. aeruginosa PAO1 WT by the
fluoroquinolone ciprofloxacin and the aminoglycoside gentamicin
was monitored after a 2 h pre-incubation period with LL-37. The
peptide itself did not affect bacterial growth as confirmed by
determination of OD600. Colony forming units (CFUs) were
counted after indicated time points during incubation with
antibiotics and compared to cell numbers of control cultures
without LL-37 pre-incubation. For ciprofloxacin, we observed an
increased resistance of LL-37-treated bacteria compared to the
untreated P. aeruginosa cultures already after 30 min of incubation.
At this time point, CFU counts revealed only a 2-fold log reduction
for LL-37-treated bacteria, but a more than 3-fold log reduction
for controls without peptide treatment. After 90 min of incubation,
no surviving bacteria in the control group could be detected,
whereas P. aeruginosa cultures, which were pre-grown with LL-37,
still showed cell numbers of approximately 220 CFU/ml
(Figure 2A). Similar results were obtained with gentamicin,
however, killing of bacteria was slower and less efficient compared
to ciprofloxacin. During the first 30 min of incubation, both LL-
37-treated and control bacteria showed a comparable 2-fold log
reduction of culturable cells. CFU counts after 60 min demon-
strated a beginning resistance of LL-37-treated cells (26104 CFU/
ml) compared to untreated controls (26103 CFU/ml). After
90 min control cultures contained only 150 CFU/ml, whereas
pre-incubation with LL-37 significantly increased cell numbers up
to 6800 CFU/ml (Figure 2B). Statistical significance of differences
between LL-37-treated bacteria and untreated controls at the end
point of the experiment after 90 min of incubation with antibiotics
was confirmed by a two-sided t-test for independent samples (p-
value ,0.001 for both antibiotics). Taken together, we could show
that P. aeruginosa resistance to both fluoroquinolone and amino-
glycoside antibiotics was enhanced by pre-incubation with the
human cathelicidin LL-37.
Virulence-associated Metabolite Production is Increased
during LL-37 Treatment
As shown by our microarray analyses, LL-37 treatment of P.
aeruginosa PAO1 induced the expression of several gene clusters
which are known to be involved in the production of virulence-
associated metabolites such as las, pqs, phz and hcn genes (Table 3).
To examine whether this upregulation of gene expression
directly leads to an enhanced secretion of virulence factors, levels
of pyocyanin, PQS, elastase and HCN were quantified in the
bacterial supernatant. For elastase, pyocyanin and PQS determi-
nation, supernatants were analyzed after 21 h of incubation with
LL-37 in order to ensure an accumulation of adequate amounts of
metabolites for subsequent measurements. OD600 values after 21 h
of incubation were only marginally decreased in LL-37-treated
cultures compared to control cultures (p = 0.14; difference not
statistically significant) and therefore LL-37 independent effects of
divergent cell densities on quorum sensing and virulence factor
levels could be excluded. Photometric determination of elastase
expression and pyocyanin synthesis revealed significantly increased
elastase (+1.4-fold) and pyocyanin (+5-fold) levels during LL-37
incubation compared to untreated controls (Figure 3A and 3B).
Moreover, the LL-37-treated bacterial cultures in contrast to
control cultures appeared intensely green (Figure S1), which was
most likely due to the elevated levels of the green-blue fluorophore
pyocyanin [6]. PQS content in bacterial supernatants was
measured using LC-MS/MS and showed 3-fold higher levels in
response to LL-37 as well (Figure 3C). HCN quantification also
demonstrated increased HCN/CN2 levels in the supernatants of
LL-37-treated bacteria compared to the untreated controls
(Table 5). In conclusion, we could show, that the cathelicidin
LL-37 not only affected the expression of various genes which are
involved in quorum sensing cascades and virulence phenotype of
P. aeruginosa, but was also able to directly enhance the secretion of
toxic metabolites pyocyanin, elastase, PQS and HCN.
Involvement of pqsE in the Response of P. aeruginosa
PAO1 to LL-37
Microarray analysis of P. aeruginosa PAO1 cells treated with LL-
37 (20 mg/ml) indicated a dysregulation of 20 genes, of which 9
genes were more than 1.5-fold upregulated, whose gene products
exhibit potential roles as transcriptional regulators (see Tables S2
and S3). In addition, we observed an increased expression of
virulence regulator PA1000 (pqsE) (Table 3), the fifth gene of the
PQS biosynthesis operon pqsABCDE. In order to analyze whether
the increased biosynthesis of secreted virulence factors and the
enhanced expression of efflux pumps MexCD-OprJ and Mex-
GHI-OpmD in response to LL-37 was influenced by pqsE
expression, we performed qRT-PCR experiments using a pqsE
transposon insertion mutant (Mutant ID PAO1_lux_76:C11) of
the PAO1mini-Tn5 lux transposon mutant library [38], which was
either grown for 2 h in the presence or absence of LL-37. Whereas
expression of efflux pump gene mexD and one gene of the LPS
modification operon, arnT, still remained induced in response to
LL-37 in the PAO1-pqsE mutant, our results demonstrated no
alterations in the expression of genes mexH, hcnB, lasB and phzC in
the PAO1-pqsE mutant treated with LL-37 compared to untreated
PAO1-pqsE (Table 4). These findings suggest an involvement of
pqsE in the regulation of our observed LL-37 induced adaptive
resistance and virulence factor production in P. aeruginosa. To
Table 4. qRT-PCR analysis of P. aeruginosa PAO1 WT and
PAO1-pqsE mutant gene expression in response to LL-37
(20 mg/ml)a.
Gene PAO1 WT PAO1-pqsE
PA4598 (mexD) 1.860.1b 1.960.2
PA4206 (mexH) 7.560.4 1.060.1
PA1000 (pqsE) 1.760.3 n.d.
PA3724 (lasB) 2.660.5 0.860.2
PA2194 (hcnB) 1.860.3 0.860.1
PA1901 (phzC2) 2.860.4 1.060.3
PA4776 (pmrA) 1.660.2 0.960.2
PA3556 (arnT) 1.560.2 1.860.2
aMid-log phase cultures of P. aeruginosa PAO1 WT or PAO1-pqsE were grown in
MH broth containing either 20 mg/ml LL-37 or no LL-37 (control) for 2 h at 37uC
following RNA isolation and qRT-PCR analysis.
bMean averages and standard deviations of three independent experiment,
each analyzed at least in duplicate (n$6). ct values were normalized against
expression of housekeeping gene rpoD. Fold changes in gene expression of LL-
37-treated cells compared to untreated controls were calculated using the DDct
method [67]. n.d.: not determined.
doi:10.1371/journal.pone.0082240.t004
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further investigate whether pqsE induction could represent a
general response of P. aeruginosa to cationic peptides, we quantified
pqsE expression after 2 h of incubation with the synthetic peptides
IDR-1018, 1037 and HHC-36 (20 mg/ml each), but observed no
changes in pqsE transcriptional levels in case of IDR-1018 (fold
change +1.260.1) or rather a downregulation in case of 1037 (fold
change 22.760.7) and HHC-36 (fold change: 23.060.7) in
comparison to untreated bacteria.
Discussion
The notable repertoire of virulence factors and the ability to
rapidly develop adaptive resistances against antibiotics are two
crucial factors for the great success of P. aeruginosa as an
opportunistic human pathogen [2,6]. Here we demonstrate that
both, virulence factor production as well as the adaptive resistance
against fluoroquinolone and aminoglycoside antibiotics, are
considerably stimulated by the host defense peptide LL-37, when
applied at concentrations that are comparable to the high LL-37
levels found in body fluids at sites of inflammation. Microarray
data of LL-37-treated P. aeruginosa cells revealed an upregulation of
quorum sensing genes pqsABCDE and significantly increased PQS
levels in bacterial supernatants. PQS functions as a signaling
molecule in cell-to-cell communication of P. aeruginosa and affects
various cellular processes such as virulence, biofilm formation,
swarming motility, antibiotic susceptibility and iron binding in an
autoinduction mechanism which is dependent on a threshold
concentration of PQS [6]. Since cell densities of LL-37-treated
cultures and untreated controls were comparable after 2 h as well
as after 21 h of incubation, growth effects as a factor influencing
the level of quorum sensing signaling molecules and virulence
factor production could be ruled out.
In contrast to PAO1 WT, expression of virulence factor genes
and of efflux operon mexGHI-opmD was not enhanced in the
PAO1-pqsE mutant during LL-37 incubation. These results
indicate a regulatory function of pqsE in the adaptation to LL-
37, which is comparable to the response to human peptide
neuromodulator dynorphin [21] and its synthetic equivalent
U50,488 in P. aeruginosa [20]. PqsE (PA1000), although located in
one operon together with pqsABCD, is not implicated in PQS
biosynthesis. Instead, it has been shown to influence the expression
of more than 600 different genes, thus controlling e.g. the
production of virulence factors phenazine, rhamnolipids, elastase
and HCN and is required for full virulence of P. aeruginosa in mice
[39,40]. Although the recently solved crystal structure of PqsE and
amino acid sequence analyses predict a hydrolase activity, there is
still a controversy in the literature concerning the precise protein
function [41]. Several studies showed that the inducing effect of
PqsE on phenazine biosynthesis is controlled by the transcriptional
regulator PqsR (MvfR) [40,42,43], whereas Farrow et al. observed
a RhlR dependent stimulation of virulence factor production by
PqsE also in the absence of PqsR [44]. Interestingly, our
microarray analysis indicated no induction of major quorum
sensing regulators lasR, lasI, rhlI, rhlR or mvfR. In accord with this,
these genes were either unaffected or downregulated by U50,488
and the described induction of virulence and adaptive resistance
genes was proposed to be regulated by pqsE alone in a yet
unknown mechanism [20]. Cummins et al. reported an enhanced
Figure 3. Quantification of metabolites elastase (A), pyocyanin (B) and PQS (C) in PAO1 WT supernatants after 21 h incubation
without or with LL-37.Mid-log phase cultures of PAO1 WT were grown in MH broth containing either 20 mg/ml LL-37 or no LL-37 (control) for 21 h
at 37uC. OD600 values after 21 h were comparable in treated samples and controls, indicating no growth inhibition by LL-37. Elastase activity (A) and
pyocyanin concentration (B) in bacterial supernatants were determined photometrically. PQS levels (C) were quantified by LC-MS/MS. Boxes include
median (black line), 25th and 75th percentiles of normalized data (n$6). Statistical significance was calculated by Mann-Whitney-Test (**: p#0.01, ***:
p#0.001).
doi:10.1371/journal.pone.0082240.g003
Figure 2. Time-killing of P. aeruginosa PAO1 by antibiotics ciprofloxacin (A) or gentamicin (B) in the absence or presence of LL-37.
Mid-log phase bacterial cultures were incubated with either 20 mg/ml LL-37 (filled circles) or without LL-37 (open squares) for 2 h. Following dilution
of bacterial cultures to 107 cells/ml and addition of 3-fold MIC concentrations of antibiotics ciprofloxacin (0.18 mg/ml) or gentamicin (1.5 mg/ml),
colony forming units at indicated time points were determined using the optimized drop plate method [27]. Experiments were performed in
triplicate. The figure shows representative results of one experiment. Error bars indicate standard deviations of 10 spots per sample plated out on two
different agar plates (n = 10).
doi:10.1371/journal.pone.0082240.g002
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expression of pqsB, pqsE, phzF and rhlB in P. aeruginosa PAO1, in
conjunction with an increased virulence against Lactobacillus
rhamnosus in response to sublethal concentrations of the cationic
antibiotic colistin [24].
In the present study, only LL-37, but none of the synthetic
cationic peptides IDR-1018, 1037 and HHC-36 were able to
induce pqsE expression, although they all target the outer cell
membrane of Gram-negative bacteria in order to evolve their
antibacterial actions [9]. Hence, the activation of pqsE expression
and downstream effects appear to be dependent on other factors
such as peptide structure or chemical properties. IDR-1018, 1037
and HHC-36 are small synthetic, 9 to 12 amino acid containing
cationic peptides, based on the linear peptide Bac2A [45,46,47].
Studies on IDR-1018 structure revealed a b-turn conformation
[45], whereas the 37 residue peptide LL-37 forms an a-helix
during interaction with lipid bilayers [48]. In contrast to these
linear peptides, polypeptide colistin (polymyxin E) exhibits a cyclic
structure [24]. One main difference between pqsE affecting agents
(LL-37, colistin, dynorphin and U50,488) and the synthetic
peptides which showed no influence on pqsE expression (IDR-
1018, 1037 and HHC-36), is the molecular mass of the agents, but
whether this attribute is critical for the demonstrated induction of
pqsE signal pathways, requires further investigation.
Moreover, our microarray data revealed an increased expres-
sion of the efflux operon mexGHI-opmD, which is implicated in the
resistance against antibiotics norfloxacin [49] and vanadium [36].
In addition, mexGHI-opmD functions as a regulator of PQS and
AHL synthesis and promotes quorum sensing and virulence in P.
aeruginosa, presumably by exporting toxic quinolone intermediates
[37]. Conversely, mexGHI-opmD expression is under the control of
PQS and PqsE [39,50] and has been recently shown to be directly
regulated by pyocyanin in a SoxR dependent pathway [51].
Interestingly, only phenazine and PQS gene expression, but not
the expression of transcriptional regulator SoxR was upregulated
in response to LL-37 in our microarrays, suggesting the
involvement of an alternative regulator in the observed induction
of mexGHI-opmD. In contrast to our results, Cummins et al. [24] did
not observe an upregulation of mexGHI-opmD operon by colistin -
although pqsE and phzF expression was induced - emphasizing,
again, the complex regulation of virulence and adaptive resistance
in P. aeruginosa in response to different environmental stimuli.
Additionally to the enhanced production of toxic, virulence-
associated compounds, we noticed an adaptive resistance of P.
aeruginosa against antibiotic ciprofloxacin after LL-37 treatment.
The response of P. aeruginosa against fluoroquinolone ciprofloxacin
and its resistome has been extensively studied and reveals a
complex regulation and an involvement of hundreds of different
genes [52,53], including RND efflux pumps MexAB-OprM,
MexCD-OprJ and MexEF-OprN [3]. Since MexCD-OprJ was
upregulated in reponse to LL-37 in our transcriptional analyses,
the adaptive resistance against ciprofloxacin could be due, at least
in parts, to this efflux pump induction. MexCD-OprJ efflux system
is not expressed in wild-type P. aeruginosa under normal growth
conditions, but can be initiated by mutations of repressor nfxB. In
previous studies, this activation caused adaptive resistances to
various substrates of MexCD-OprJ including macrolides, chlor-
amphenicol, tetracycline and fluoroquinolones [54,55] and led to a
strain-specific induction of virulence [55]. It has been shown
recently, that P. aeruginosa mexCD-oprJ expression is also stimulated
by cationic biocides benzalkonium chloride and chlorhexidine
gluconate [56,57] and by other components causing membrane
damage and envelope stress such as ethanol, SDS, polymyxin B
and the antimicrobial peptides V8 and V681 in an algU-dependent
pathway [57]. However, LL-37, although it is known to act as a
cell membrane-damaging agent [58], did not cause alterations in
algU sigma factor expression (see Tables S2 and S3) and the main
regulator of MexCD-OprJ, the repressor nfxB, was rather
upregulated than downregulated. These findings suggest the
existence of an alternative peptide inducible regulator of
MexCD-OprJ expression. Although previous experiments from
other groups demonstrate that PqsE acts as positive regulator of
mexCD-oprJ expression [20,39], our qRT-PCR results indicate that
other regulators may override the lack of PqsE in reponse to LL-37
leading to equally increased mexD levels in the PAO1-pqsE mutant
as in the wild-type bacteria.
In addition to the increased ciprofloxacin resistance, suscepti-
bility of P. aeruginosa to aminoglycoside gentamicin was also
reduced following LL-37 treatment. Similar results have been
reported for Streptococcus pneumonaiae and erythromycin [59]. Since
aminoglycosides are mainly exported by the inducible efflux
system MexXY-OprM [3], which was not affected by LL-37 in
this study, the observed gentamicin resistance has to be caused by
other factors. One possible explanation refers to the enhanced
expression of the LPS modifying operon arnBCDTEFugd which
mediates resistance to aminoglycosides and other cationic antibi-
otics [4]. In accord with a previous study [9], we observed a 1.9-
fold increase in pmrA expression by LL-37, which is involved in arn
regulation, whereas other two-component systems controlling arn
expression, ParR-ParS [12], PhoP-PhoQ [10] and the recently
identified system CprR-CprS [13], were not affected. Since arnT
expression, but not pmrA expression, were stimulated in the PAO1-
pqsE mutant by LL-37, the observed induction of arnBCDTEFugd
expression seems to be independent of both, pmrA and pqsE.
Our observations that virulence factor production and adaptive
resistance in response to LL-37, are in parts influenced by PqsE in
a yet unknown manner emphasize the crucial role of quorum
sensing in P. aeruginosa infections and the high potential of quorum
sensing inhibitors as promising agents against infections caused by
multi-resistant bacteria, as mentioned previously [60]. Since
several cationic peptides, including LL-37, exhibit a potent
antibiofilm activity, in several cases in combination with a direct
antimicrobial activity against various bacterial species, their
prospective medical application is widely discussed [15]. The
possibility, that cationic compounds structurally related to LL-37
could be able to affect virulence and adaptive resistance in P.
aeruginosa in a similar way, may limit their use as sole drug during
infectious diseases and should be considered in further investiga-
tions.
Table 5. HCN/CN2 concentrations in PAO1 WT
supernatantsa.
Sample HCN/CN2 [mg/l]b
PAO1+ LL-37 899631
PAO1 control 475618
aMid-log phase cultures of PAO1 WT were grown in MH broth containing either
20 mg/ml LL-37 or no LL-37 (control) for 2 h at 37uC. Cell densities after 2 h
peptide treatment were comparable in treated samples and controls, indicating
no growth inhibition by LL-37. Supernatants were prepared by centrifugation
following polarographic determination of HCN/CN2 content.
bMean averages and pooled standard deviations of three experiments, each
measured in triplicate (n = 9). Statistical significance of differences between
mean values was confirmed by a two-sided t-test for independent samples
(p,0.001).
doi:10.1371/journal.pone.0082240.t005
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Supporting Information
Figure S1 P. aeruginosa PAO1 cultures after 21 h of
incubation with LL-37 (left) or without LL-37 (right) in
MH medium under shaking conditions at 376C.
(TIF)
Table S1 qRT-PCR primers for detection of P. aeruginosa PAO1
gene expression.
(PDF)
Table S2 Full list of upregulated genes (fold change$1.5) in
response to 20 mg/ml LL-37 compared to non-treated P. aeruginosa
PAO1.
(PDF)
Table S3 Full list of downregulated genes (fold change$1.5) in
response to 20 mg/ml LL-37 compared to non-treated P. aeruginosa
PAO1.
(PDF)
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